Literature DB >> 26108735

Remaining cancer cells within the fibrosis after neo-adjuvant treatment for locally advanced rectal cancer.

S Tanaka1, A Martling2, J Lindholm3, T Holm2, G Palmer4.   

Abstract

AIM: To analyse the incidence and distribution of remaining cancer cells within the fibrosis induced by preoperative chemo-radiotherapy (CRT) for locally advanced rectal cancer.
METHODS: The histopathological specimens from 46 patients operated on with extensive surgery for locally advanced rectal cancer after CRT were examined. The extension of fibrosis in relation to the mesorectal fascia (MRF) and the distribution of cancer cells within the fibrosis was examined using routine haematoxylin-eosin staining. In addition, immunohistochemical staining with CK20 was done to examine if cancer cells were missed by routine pathological work up.
RESULTS: All specimens showed CRT induced fibrosis. Two specimens showed complete response without viable cancer cells (ypT0). The fibrosis was limited inside the MRF in three cases, adherent to or involved the MRF in ten cases and in 33 cases the fibrosis was obvious outside as well as inside the fascia. Twenty-one cases showed fibrosis on the surgical resection margin, and in 9 of these cancer cells were found on the surgical margin (R1, R2-resection). 37 patients had R0 resections and among those 24 showed fibrosis beyond the MFR and 13 had scattered cancer cells in the fibrosis along or outside the MRF.
CONCLUSIONS: The rate of remaining cancer cells within the fibrosis was high in patients with locally advanced rectal cancer treated with CRT. Frequently cancer cells were detected near the border of the fibrosis. A complete resection of the fibrosis is therefore recommended to achieve an R0 resection after neo-adjuvant treatment.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fibrosis; Local recurrence; Locally advanced rectal cancer; Mesorectal fascia (MRF); Preoperative chemoradiotherapy (CRT)

Mesh:

Substances:

Year:  2015        PMID: 26108735     DOI: 10.1016/j.ejso.2015.05.019

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  2 in total

1.  The use of transureteroureterostomy during ureteral reconstruction for advanced primary or recurrent pelvic malignancy in the era of multimodal therapy.

Authors:  Junichiro Kawamura; Masaki Tani; Kimiaki Sumida; Takefumi Yazawa; Junya Kawasoe; Michihiro Yamamoto; Hideki Harada; Hidekazu Yamamoto; Masazumi Zaima
Journal:  Int J Colorectal Dis       Date:  2016-10-06       Impact factor: 2.571

2.  Long-term survival and cure model following liver resection for breast cancer metastases.

Authors:  Aldrick Ruiz; Mylène Sebagh; Dennis A Wicherts; Carlos Castro-Benitez; Richard van Hillegersberg; Bernard Paule; Denis Castaing; Eric Vibert; Antonio Sa Cunha; Daniel Cherqui; Jean-François Morère; René Adam
Journal:  Breast Cancer Res Treat       Date:  2018-02-20       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.